Additionally, in hepatocellular carcinoma, STIL expression has been linked to immune cell infiltration and immune checkpoint expression and has been proposed as a predictive marker for immunotherapy and chemotherapy efficacy [30]. The gene discussed is STIL; the disease is hepatocellular carcinoma.